lauralea

Deeply Oversold

lauralea Updated   
NYSE:INSP   Inspire Medical Systems, Inc.
Price is below the bands set on an 80 DMA which indicates oversold status.
Bollinger Bands are also an oversold/overbought indicator.
RSI is also deeply oversold.

This company does not have positive EPS but growth must be expected for price to go as high as it did.
Possibly the overvaluation caused the fall.
No recommendation.

52 Week Range
159.62
330.00
Day Range
211.75
216.07
EPS (FWD)
-1.73
PE
-
Div Rate (TTM)
-
Yield (TTM)
-
Short Interest
2.60%
Market Cap
$6.31B
Volume
115,589

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.




Comment:
Price can stay overbought or oversold for extended periods of time
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.